These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31097715)

  • 21. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
    [No Abstract]   [Full Text] [Related]  

  • 22. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
    Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
    Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133
    Hemati H; Kaur J; Sobti RC; Trehanpati N
    Biochem Biophys Res Commun; 2020 May; 525(4):941-947. PubMed ID: 32173531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
    Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells.
    Paul S; Chatterjee S; Sinha S; Dash SR; Pradhan R; Das B; Goutam K; Kundu CN
    Expert Opin Ther Targets; 2023; 27(10):999-1015. PubMed ID: 37787493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells.
    Ballout F; Monzer A; Fatfat M; Ouweini HE; Jaffa MA; Abdel-Samad R; Darwiche N; Abou-Kheir W; Gali-Muhtasib H
    Oncotarget; 2020 Aug; 11(31):2959-2972. PubMed ID: 32821342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
    Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
    Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
    Kim D; Park M; Jang H; Hyun H; Lim W
    Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
    Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
    BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
    Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
    Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.
    Hu Y; Yan C; Mu L; Huang K; Li X; Tao D; Wu Y; Qin J
    PLoS One; 2015; 10(5):e0125625. PubMed ID: 25938772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.
    Xu K; Shen K; Liang X; Li Y; Nagao N; Li J; Liu J; Yin P
    Oncotarget; 2016 Nov; 7(46):75118-75129. PubMed ID: 27738333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting colorectal cancer stem cells with inducible caspase-9.
    Kemper K; Rodermond H; Colak S; Grandela C; Medema JP
    Apoptosis; 2012 May; 17(5):528-37. PubMed ID: 22223359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
    Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.